Top Safest Stocks To Watch For 2019

tags:CTL,DNOW,BTG,THQ, 303 Days to Go

Today in Brexit: With Italy dominating the headlines, a prominent anti-Brexit voice has a warning for the EU.

Less than two years after the Brexit vote, a new crisis is brewing in Europe.

Political turmoil in Italy rocked global markets yesterday, sparked by the prospect of anti-Europe, nationalist parties turning an election into a de facto referendum on Italy’s membership of the euro. Bond yields soared and the single currency fell. The British pound didn’t escape the selloff, falling to a six-month low against the dollar as investors sought the safest assets.

The turbulence, greeted with glee by some pro-Leave campaigners in Britain, recalls the chaos of the region’s debt crisis earlier this decade. It also serves as a timely reminder that the U.K.’s rocky process toward the exit isn’t quelling anti-EU movements across the continent, and that Europe’s problems do not stop at Brexit.

Top Safest Stocks To Watch For 2019: CenturyLink, Inc.(CTL)

Advisors' Opinion:

• [By Jason Hall]

  If you bought this time last year,�Centurylink Inc.�(NYSE:CTL)�and�Pattern Energy Group Inc.�(NASDAQ:PEGI)�haven't exactly been great investments, with share prices down 33% and 19%, respectively, while the�S&P 500�(SNPINDEX:^GSPC)�has gained 15%. Even when we factor in dividends, they lost investors money while the market delivered more than 17% in total returns.�

• [By Logan Wallace]

  Tredje AP fonden increased its holdings in shares of Centurylink Inc (NYSE:CTL) by 14.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 54,920 shares of the technology company’s stock after purchasing an additional 6,960 shares during the period. Tredje AP fonden’s holdings in Centurylink were worth $902,000 as of its most recent filing with the Securities and Exchange Commission.

• [By Jamal Carnette, CFA]

  CenturyLink (NYSE:CTL) has become a battleground stock among income investors. On one hand, the company's outsized dividend attracts yield-hungry investors. On the other, bearish investors cite increased pressure as more consumers cancel their landline telephone connections and cut the cord. Eventually, they argue, the company will be forced to cut its massive dividend and the share price will plummet.

Top Safest Stocks To Watch For 2019: NOW Inc.(DNOW)

Advisors' Opinion:

• [By Logan Wallace]

  National Oilwell Varco (NYSE: NOV) and DistributionNOW (NYSE:DNOW) are both oils/energy companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability.

• [By Shane Hupp]

  Shares of DistributionNOW (NYSE:DNOW) have been given an average rating of “Hold” by the fourteen ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $12.50.

• [By Logan Wallace]

  ValuEngine upgraded shares of DistributionNOW (NYSE:DNOW) from a strong sell rating to a sell rating in a report published on Friday.

  A number of other research analysts have also recently commented on the company. TheStreet upgraded DistributionNOW from a d+ rating to a c rating in a research note on Wednesday, May 16th. Stifel Nicolaus boosted their price objective on DistributionNOW from $13.00 to $15.00 and gave the stock a buy rating in a research note on Thursday, May 3rd. Cowen restated a market perform rating and set a $11.00 price objective (up previously from $9.00) on shares of DistributionNOW in a research note on Thursday, May 3rd. Susquehanna Bancshares set a $11.00 price objective on DistributionNOW and gave the stock a hold rating in a research note on Friday, April 13th. Finally, Credit Suisse Group restated a neutral rating and set a $10.00 price objective (down previously from $12.00) on shares of DistributionNOW in a research note on Tuesday, February 27th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of $13.00.

• [By Stephan Byrd]

  Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

  Get Alaska Air Group alerts: 68 percent of flight attendants say they have experienced sexual harassment on the job (finance.yahoo.com) ValuEngine Lowers Alaska Air Group (ALK) to Sell (americanbankingnews.com) Enamoring Five Stocks: Fitbit, Inc. (NYSE:FIT), Alaska Air Group, Inc. (NYSE:ALK), NOW Inc. (NYSE:DNOW), Leidos … (thestreetpoint.com) Average True Range under Trader’s Radar �� Alaska Air Group (NYSE: ALK) (stocktradingdesk.com) Undertaking Stocks: Incyte Corporation (NASDAQ:INCY), Alaska Air Group, Inc. (NYSE:ALK), Innoviva, Inc. (NASDAQ … (journalfinance.net)

  ALK has been the topic of a number of recent analyst reports. Morgan Stanley set a $78.00 price objective on Alaska Air Group and gave the stock a “buy” rating in a report on Friday, February 23rd. Stifel Nicolaus reaffirmed a “buy” rating and set a $105.00 price objective (down previously from $115.00) on shares of Alaska Air Group in a report on Wednesday, January 10th. Buckingham Research dropped their price objective on Alaska Air Group from $90.00 to $88.00 and set a “buy” rating on the stock in a report on Friday, January 26th. TheStreet lowered Alaska Air Group from a “b-” rating to a “c+” rating in a report on Monday, April 2nd. Finally, Barclays lowered Alaska Air Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $90.00 to $80.00 in a report on Wednesday, January 10th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $85.00.

Top Safest Stocks To Watch For 2019: B2Gold Corp(BTG)

Advisors' Opinion:

• [By Joseph Griffin]

  CIBC World Markets Inc. reduced its holdings in B2Gold Corp. (NYSEAMERICAN:BTG) (TSE:BTO) by 10.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 572,525 shares of the basic materials company’s stock after selling 64,714 shares during the period. CIBC World Markets Inc. owned approximately 0.06% of B2Gold worth $1,563,000 as of its most recent SEC filing.

• [By Stephan Byrd]

  Deutsche Bank reaffirmed their hold rating on shares of BTG (LON:BTG) in a report released on Wednesday.

  A number of other equities research analysts have also weighed in on BTG. Shore Capital upgraded BTG to a buy rating in a research report on Monday, March 26th. Peel Hunt restated a hold rating and set a GBX 700 ($9.32) price objective on shares of BTG in a research report on Wednesday, April 4th. JPMorgan Chase & Co. reduced their price objective on BTG from GBX 750 ($9.99) to GBX 680 ($9.05) and set a neutral rating on the stock in a research report on Friday, April 6th. Jefferies Financial Group boosted their price objective on BTG from GBX 775 ($10.32) to GBX 900 ($11.98) and gave the stock a buy rating in a research report on Tuesday, May 15th. Finally, Numis Securities reiterated a buy rating and issued a GBX 840 ($11.18) price target on shares of BTG in a research report on Tuesday, May 15th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of Buy and an average price target of GBX 745.83 ($9.93).

• [By Max Byerly]

  Here’s how other cryptocurrencies have performed during the last day:

  Get Bitgem alerts: Zcash (ZEC) traded 7.4% lower against the dollar and now trades at $243.26 or 0.03355620 BTC. Bitcoin Gold (BTG) traded 6% lower against the dollar and now trades at $41.47 or 0.00572057 BTC. Bitcoin Private (BTCP) traded up 1.3% against the dollar and now trades at $22.93 or 0.00316296 BTC. ZenCash (ZEN) traded 7.9% lower against the dollar and now trades at $29.94 or 0.00412942 BTC. ZClassic (ZCL) traded down 2.8% against the dollar and now trades at $11.31 or 0.00155982 BTC. BitcoinZ (BTCZ) traded 0.5% lower against the dollar and now trades at $0.0019 or 0.00000026 BTC. Hush (HUSH) traded 0.7% lower against the dollar and now trades at $0.83 or 0.00011450 BTC. Zero (ZER) traded up 13% against the dollar and now trades at $0.58 or 0.00008000 BTC. VoteCoin (VOT) traded 3.3% lower against the dollar and now trades at $0.0127 or 0.00000175 BTC. Bitcoin Interest (BCI) traded up 0.2% against the dollar and now trades at $4.83 or 0.00066692 BTC.

  Bitgem Profile

Top Safest Stocks To Watch For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors' Opinion:

• [By Ethan Ryder]

  Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Shares of Cleveland-Cliffs Inc. Pop 10% as Second-Quarter Earnings Surge

What happened?

Shares of Cleveland-Cliffs Inc. (NYSE:CLF), the largest and oldest iron-ore mining company in the U.S., were up 10% as of 3:14 p.m. EDT Friday after the company announced better than expected second-quarter results.

So what

The company reported consolidated revenues of $714 million, significantly better than the prior year's $471 million, and higher than analysts' estimates of $692.2 million, per analysts surveyed by investment research firm Zacks. Income from continuing operations jumped to $229 million, or $0.76 per diluted share, which was again a large improvement from the prior year's $84 million, or $0.28 per share, and well ahead of analysts' estimates calling for $0.56 per share, per Zacks. Another bright spot was a 16% increase in its U.S. iron-ore realized revenue rate.

Image source: Getty Images.

President and CEO Lourenco Goncalves said in a press release: "Our second quarter is a definitive statement about the new Cliffs and our earnings power. After almost four years of consistent execution of a well-designed and thoroughly implemented strategy, our company has become a very powerful cash-generating enterprise."

Now what

It's understandable that investors pushed the stock higher today. The second-quarter surge in earnings reflects an end, or near-end, to its multiyear transformation to get back to its roots as a supplier of high-grade iron units. Now that the company is focused on its roots, it expects to generate cash this year at a level it hasn't seen in years, and for that strong momentum to continue into 2019. Business is looking good, and today's 10% jump means investors are buying into its future potential.

Merck lowers some drug prices after Trump blasts

U.S. pharmaceutical giant Merck said Thursday that it will limit drug price increases and lower the price of several treatments.

Repeatedly slammed by President Donald Trump over drug prices,�the Kenilworth, N.J.-based company did not reference Trump in making the announcement.

But the company said it would "commit to not increase the average net price across our portfolio of products by more than inflation annually."

The "net price" is a cloudy figure�that can be difficult to assess because it may include the value of complex industry rebates and insurance reimbursements. Still,�the move reflects a step toward limiting the impact of drug costs on American consumers.

It also comes after Pfizer last week temporarily reversed price increases following criticism from Trump.

Pfizer, Merck and other drug companies have repeatedly been the subject of Trump's wrath.

"@Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!" Trump said on Twitter in August.

That Trump tweet came on the same day that Merck CEO Kenneth Frazier resigned from a presidential manufacturing council amid dissatisfaction with the president's response to white supremacist protests in Charlottesville, Va.

"America's leaders must honor our fundamental values by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all people are created equal," Frazier wrote at the time.

Merck said Thursday that its plans include a 60 percent price cut on�hepatitis C treatment Zepatier and a 10 percent cut on "several other medicines."

The company said it picked the products based on the "gap between list price and actual discounted (net) prices paid in the market, the contractual obligations under existing arrangements with payers, and the opportunity to broaden access to treatment."

More: Pfizer reverses drug price increases after President Trump blasted the company

More: President Trump slams Pfizer drug price increases, threatens action

More: Donald Trump vows to lower 'soaring' drug prices but abandons campaign idea

A bipartisan chorus of politicians, including Trump, have long criticized the drug industry over prices. But there's no indication of any significant pending policy action aimed at regulating prices, bolstering competition or some�other potential solution.

In May, Trump's administration issued a 44-page blueprint detailing his strategy to cut drug prices. But critics said it lacked aggressive maneuvers required to make a dent, such as potentially allowing Medicare to use its purchasing power to negotiate directly with drug companies.

"We will have tougher negotiation, more competition and much lower prices at the pharmacy counter," Trump said at the time. "And it will start to take effect very soon."

Merck said�Thursday, "Going forward, we will continue to evaluate our portfolio of products to look for opportunities to further reduce costs for patients and the health care system."

Follow USA TODAY reporter Nathan Bomey on Twitter @NathanBomey.

Top Biotech Stocks To Buy For 2019

tags:TLT,OPK,BBRY,

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Sun Pharmaceuticals' biologic approved for plaque psoriasis

Company: Sun Pharmaceuticals (OTCPK:SMPQY)

Therapy: Tildrakizumab-asmn

Disease: Plaque psoriasis

News: Indian pharma SMPQY announced that the FDA has approved their IL-23 antibody tildrakizumab-asmn for the treatment of moderate-to-severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy. This approval was based on the findings from two randomized, placebo-controlled trials showing significant clearance of plaque psoriasis compared with placebo.

Looking forward: With this approval, SMPQY enters a rather crowded field full of effective options for plaque psoriasis, including other therapies targeting interleukins, including the IL-23-directed antibody guselkumab. However, in spite of this rather heavy competition, SMPQY are likely going to be able to make a return on their investment with this approval, and the pie of plaque psoriasis is over $10 billion in the US alone.

Top Biotech Stocks To Buy For 2019: iShares 20+ Year Treasury Bond (TLT)

Advisors' Opinion:

• [By Shane Hupp]

  iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) announced a monthly dividend on Monday, July 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, July 3rd will be given a dividend of 0.2749 per share by the exchange traded fund on Monday, July 9th. This represents a $3.30 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, July 2nd.

• [By Stephan Byrd]

  NEXT Financial Group Inc raised its position in Ishares Lehman 20 Year (NASDAQ:TLT) by 30.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 10,785 shares of the exchange traded fund’s stock after acquiring an additional 2,489 shares during the period. NEXT Financial Group Inc’s holdings in Ishares Lehman 20 Year were worth $1,315,000 at the end of the most recent reporting period.

• [By WWW.GURUFOCUS.COM]

  For the details of Nationwide Fund Advisors's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Nationwide+Fund+Advisors

  These are the top 5 holdings of Nationwide Fund AdvisorsiShares Core MSCI Emerging Markets (IEMG) - 4,698,924 shares, 74.25% of the total portfolio. Shares added by 119.53%iShares 20+ Year Treasury Bond ETF (TLT) - 536,574 shares, 17.7% of the total portfolio. Shares added by 79.94%iShares iBoxx $ High Yield Corporate Bond (HYG) - 347,518 shares, 8.05% of the total portfolio. Shares reduced by 20.57%

Top Biotech Stocks To Buy For 2019: Opko Health Inc(OPK)

Advisors' Opinion:

• [By ]

  Opko Health (OPK) : "I've been waiting for these guys to come back on the show and tell us why we should buy."

  International Paper (IP) : "The stock is down big. I say at these prices it's a good buy."

• [By Keith Speights]

  If you're looking for stocks that have made tremendous comebacks in 2018, Opko Health (NASDAQ:OPK) and Myriad Genetics (NASDAQ:MYGN) definitely fit the bill. Opko stock was down nearly 20% this year before roaring back. Myriad Genetics saw its share price plunge close to 40% earlier in 2018, but a strong rebound has the stock price close to where it began the year.�

• [By Lisa Levin] Gainers Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday. ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings. TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday. TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results. Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent. Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results. OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat. Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday. KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings. New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results. Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings. Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Money Morning News Team]

  And after taking a look at our 10 top penny stocks to watch, we'll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq:�FB)…

  Penny Stock Current Share Price Law Week's Gain Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51% Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00% Opko Health Inc. (Nasdaq: OPK) $4.79 43.49% MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84% Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80% Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81% VAALCO Energy (NYSE: EGY) $1.49 36.04% Cel-Sci Corp. (NYSE: CVM) $3.16 35.04% WideOpenWest Inc. (NYSE: WOW) $8.41 34.52% Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

  While these gains are certainly exciting, it's important to recognize that investing in penny stocks is also a risky investment strategy.

Top Biotech Stocks To Buy For 2019: BlackBerry Limited(BBRY)

Advisors' Opinion:

• [By Shane Hupp]

  BlackBerry (TSE:BB) (NASDAQ:BBRY)‘s stock had its “in-line” rating reiterated by analysts at Imperial Capital in a report issued on Wednesday.

6 Most Important Things in Business Today

BMW posted solid financial results. According to MarketWatch:

Bayerische Motoren Werke AG said Thursday that its first-half sales rose 1.8% thanks to strong demand in Europe, the Americas and Asia.

The German premium auto maker said it sold 1.24 million cars in the first six months of the year, compared with 1.22 million a year earlier. Sales for June rose 2.7% to 238,920 units, the company said.

Broadcom Ltd. (NASDAQ: AVGO) will buy software operation CA Technologies. According to Reuters:

Broadcom Inc announced a $18.9 billion deal to buy U.S. business software company CA Inc on Wednesday, venturing far beyond its realm of semiconductors and testing investors�� confidence in its Chief Executive Hock Tan��s dealmaking credentials.

The CA deal, outlined in a joint statement from the companies, comes just four months after U.S. President Donald Trump blocked Broadcom��s $117 billion hostile bid for semiconductor peer Qualcomm Inc, arguing it posed a threat to U.S. national security and gave an edge to Chinese companies looking to build next-generation wireless networks.

Since then, Broadcom has redomiciled from Singapore to the United States, placing it formally outside the purview of the Committee on Foreign Investment in the United States (CFIUS), the government panel that reviews deals for potential national security risks.

Comcast Corp. (NASDAQ: CMCSA) increased its offer for U.K. media company Sky. According to The Wall Street Journal:

The battle for control of European pay-TV giant Sky PLC heated up Wednesday, with 21st Century Fox raising its bid and cable company Comcast Corp. quickly countering later in the day, the latest jockeying in a cross-Atlantic media deal showdown.

Comcast raised its offer for Sky to 拢14.75 per share, valuing the company at $34 billion. That is a 5% premium to an offer Fox announced earlier Wednesday and 18% above Comcast��s earlier bid. Comcast said its latest offer was recommended by Sky��s independent directors.

The founder of Papa John’s International Inc. (NASDAQ: PZZA) resigned after making racially charged comments. According to The Wall Street Journal:

Papa John��s International Inc. said late Wednesday that its independent directors have accepted the resignation of John Schnatter as board chairman, after a report that he used a racial slur in a conference call.

In a news release, the company said Olivia Kirtley will serve as lead independent director. Papa John��s will appoint a new chairman in the coming weeks.

Ford Motor Co. (NYSE: F) continues to take a beating in China:

Ford Motor Co. sales in China plunged 26% in the first half of 2018 compared with the same period last year, and there is little relief in sight as U.S.-China trade tensions worsen.

China��s auto market overall grew 5.6% in the first six months, with sales reaching 14.1 million vehicles, according to figures released Wednesday by the government-backed China Association of Automobile Manufacturers.

But Ford sold just 400,443 of those��the company��s poorest first-half showing in China since 2012. By comparison, General Motors Co. booked a record first-half performance in China, with sales increasing 4% to 1.84 million.

The International Energy Agency said oil production will be “stretched to the limit.” The organization’s experts wrote:

Some of these supply issues are likely to be resolved, but the large number of disruptions reminds us of the pressure on global oil supply. This will become an even bigger issue as rising production from Middle East Gulf countries and Russia, welcome though it is, comes at the expense of the world��s spare capacity cushion, which might be stretched to the limit.

Top 10 Small Cap Stocks To Invest In Right Now

tags:FCEL,PQ,CNR,ACHN,

In 2017, I want to stay with small cap companies but also go global, asserts fund expert Jim Lowell, editor of Fidelity Investor.

Recently, crossing the waters has been a recipe for higher volatility and lower returns.

But a sea change is affecting U.S. small caps for the better — a growing economy, a strengthening consumer, and trading with their neighbors rather than getting caught up in cross border currency wars.

These factors are also beginning to manifest themselves overseas — thanks to massive stimulus efforts underway in Europe and Japan.

My recommendation to play this trend is Fidelity International Small Cap Opportunities (FSCOX). Here, veteran multi-cap international stock picker Jed Weiss invests in small-cap companies from around the globe.

In this case, small-cap is defined as having a market-cap of $5 billion or less — so it's what the Street calls a "smid-cap" (small and mid cap) basket.

Top 10 Small Cap Stocks To Invest In Right Now: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:

• [By Paul Ausick]

  FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 43.9% in short interest during the period. Some 10.68 million shares were short as of June 29. The stock closed most recently at $1.33, down about 1.5% for the day, in a 52-week range of $1.29 to $2.49. Shares traded down more than 20% in the short interest period, and days to cover dropped from six to four.

• [By Peter Graham]

  Small cap fuel cell stock�FuelCell Energy Inc (NASDAQ: FCEL) reported Q4 and fiscal year ended October 31, 2017 earnings�with�Q4 total revenues�being $47.9 million versus $24.5 million:����

• [By Shane Hupp]

  FuelCell Energy (NASDAQ: FCEL) is one of 25 public companies in the “Miscellaneous electrical machinery, equipment, & supplies” industry, but how does it contrast to its peers? We will compare FuelCell Energy to related companies based on the strength of its risk, dividends, earnings, valuation, profitability, analyst recommendations and institutional ownership.

• [By Shane Hupp]

  Electro Scientific Industries (NASDAQ: ESIO) and FuelCell Energy (NASDAQ:FCEL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Top 10 Small Cap Stocks To Invest In Right Now: Petroquest Energy Inc(PQ)

Advisors' Opinion:

• [By Ethan Ryder]

  News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Small Cap Stocks To Invest In Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:

• [By Shane Hupp]

  Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

• [By Ethan Ryder]

  State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

• [By Stephan Byrd]

  Brokerages expect Canadian National Railway (NYSE:CNI) (TSE:CNR) to announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.10 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings of $1.00 per share in the same quarter last year, which would indicate a positive year over year growth rate of 3%. The business is scheduled to issue its next quarterly earnings report on Tuesday, July 24th.

Top 10 Small Cap Stocks To Invest In Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:

• [By Ethan Ryder]

  Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

• [By Stephan Byrd]

  Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints. MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday. Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday. Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday. Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday. Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday. Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec. Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading. Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session. LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported. Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire. HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

  Find out what's going

• [By Keith Speights]

  Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

Movers & Shakers: Volumes of Indoco Remedies & Thermax rose up to 19,000% in last 5 days

Moneycontrol News

The market is trading on a positive note this Tuesday afternoon with the Nifty up 94 points at 10,947 and the Sensex�gaining 333 points at 35,268.

Market breadth was strong with�1202 stocks advancing on the NSE,�520 declining, and 341 staying unchanged. On the other hand, in the BSE, 1665 stocks advanced and�972 declined and 139 were unchanged.

TCI Finance�has gained�30.54 percent�followed by�ITI�which gained 21.57 percent. These are�followed by�Banaras Beads�which added 21.49 percent while�Maan Aluminium�gained 20.96 percent.�Meghmani Organics�was up 18.77 percent.

Mentioned below are stocks that witnessed a surge in trading volumes on Tuesday compared to their 5-day average.

Indoco Remedies was trading with volumes of 626,938 shares, compared to its five day average of 3,213 shares, an increase of 19,410.11 percent. Thermax was trading with volumes of 256,678 shares, compared to its five day average of 1,398 shares, an increase of 18,265.63 percent.

Bhageria Industries was trading with volumes of 653,265 shares, compared to its five day average of 3,808 shares, an increase of 17,053.27 percent.

Somany Ceramics was trading with volumes of 178,315 shares, compared to its five day average of 2,019 shares, an increase of 8,731.85 percent.

Ashoka Buildcon was trading with volumes of 474,976 shares, compared to its five day average of 7,077 shares, an increase of 6,611.17 percent. First Published on Jul 10, 2018 03:35 pm

PetroDollar (XPD) Trading 0.8% Higher Over Last Week

PetroDollar (CURRENCY:XPD) traded down 5.1% against the US dollar during the twenty-four hour period ending at 21:00 PM Eastern on July 6th. Over the last week, PetroDollar has traded 0.8% higher against the US dollar. PetroDollar has a market cap of $470,643.00 and $406.00 worth of PetroDollar was traded on exchanges in the last day. One PetroDollar coin can currently be purchased for about $0.0074 or 0.00000112 BTC on major cryptocurrency exchanges including Cryptopia and YoBit.

Here’s how other cryptocurrencies have performed over the last day:

Get PetroDollar alerts: Altcoin (ALT) traded up 24.6% against the dollar and now trades at $22.64 or 0.00343891 BTC. Version (V) traded 1.5% higher against the dollar and now trades at $0.0022 or 0.00000033 BTC. UniCoin (UNIC) traded 4.8% lower against the dollar and now trades at $0.19 or 0.00002914 BTC. Prototanium (PR) traded up 20.9% against the dollar and now trades at $1.52 or 0.00023164 BTC. SproutsExtreme (SPEX) traded flat against the dollar and now trades at $0.0001 or 0.00000001 BTC. Jin Coin (JIN) traded flat against the dollar and now trades at $0.0166 or 0.00000249 BTC. AgrolifeCoin (AGLC) traded flat against the dollar and now trades at $0.0005 or 0.00000006 BTC. Magnetcoin (MAGN) traded 0.1% higher against the dollar and now trades at $0.0542 or 0.00000824 BTC.

PetroDollar Profile

PetroDollar (CRYPTO:XPD) is a coin. It launched on February 19th, 2014. PetroDollar’s total supply is 63,993,275 coins. PetroDollar’s official Twitter account is @thepetrodollar.

PetroDollar Coin Trading

PetroDollar can be bought or sold on the following cryptocurrency exchanges: Cryptopia and YoBit. It is usually not currently possible to buy alternative cryptocurrencies such as PetroDollar directly using US dollars. Investors seeking to acquire PetroDollar should first buy Bitcoin or Ethereum using an exchange that deals in US dollars such as Coinbase, Gemini or GDAX. Investors can then use their newly-acquired Bitcoin or Ethereum to buy PetroDollar using one of the aforementioned exchanges.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “XPDUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Yes Bank stock rallies 3% after SEBI approves launch of its mutual fund business

Shares of private sector lender Yes Bank rallied more than 3 percent intraday on Thursday as it received approval from capital market regulator SEBI to launch mutual fund business.

"...has received the final regulatory approval (Certificate of Registration) from the Securities & Exchange Board of India (SEBI) to commence the mutual fund business," the country's fourth largest private sector lender said in a statement.

This approval is subsequent to the Reserve Bank of India��s approval granted to the bank to sponsor a mutual fund followed by SEBI's in-principle approval received subsequently, it added.

"This strategic initiative will further complement Yes Bank's retail liabilities and wealth management strategy, and also allow YES Asset Management India (YAMIL) to build on the bank's ��DIGICAL�� distribution network to provide customers a seamless Investment and Banking experience," Rana Kapoor, Managing Director & CEO, Yes Bank said.

related news Biocon shares gain nearly 2% on EU GMP certification for Bengaluru facility Force Motors gains 4% post June sales data

The migration of this differentiated sectoral knowledge will allow YES Asset Management (India) Limited, a wholly owned subsidiary of Yes Bank, to launch fund offerings across the spectrum of both Debt & Equity markets over the next 6-12 months, the bank said.

The lender also recently received the final license from SEBI to launch its custodian of securities business. The bank will also be opening representative offices in London and Singapore as per recent approval from RBI, in addition to its presence in UAE through its representative office in Abu Dhabi.

At 10:21 hours IST, the stock price was quoting at Rs 344.80, up Rs 9.30, or 2.77 percent on the BSE. First Published on Jul 5, 2018 10:36 am